問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberDS8201-772
NCT Number(ClinicalTrials.gov Identfier)-
Active

2025-03-01 - 2032-01-31

Phase III

Recruiting7

ICD-10C56.1

Malignant neoplasm of right ovary

ICD-10C56.2

Malignant neoplasm of left ovary

ICD-10C56.9

Malignant neoplasm of unspecified ovary

ICD-10Z51.12

Encounter for antineoplastic immunotherapy

ICD-9183.0

Malignant neoplasm of ovary

-

  • Trial Applicant

     Daiichi Sankyo Taiwan Ltd. 

  • Sponsor

    -

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/05/13

Investigators and Locations

Principal Investigator Yu-Fang Huang Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Chien-Hsing Lu Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Yun-Hsin Tang Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 張志隆 Division of Obstetrics & Gynecology

Co-Principal Investigator

  • 詹雅婷 Division of Obstetrics & Gynecology
  • 王功亮 Division of Obstetrics & Gynecology
  • 陳楨瑞 Division of Obstetrics & Gynecology

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 傅宏鈞 Division of Obstetrics & Gynecology

Co-Principal Investigator

  • 王映文 Division of Obstetrics & Gynecology
  • 陳盈儀 Division of Obstetrics & Gynecology
  • 黃偲媁 Division of Obstetrics & Gynecology
  • 李仲哲 Division of Ophthalmology
  • 湯禹舜 Division of Radiology
  • 蔡景州 Division of Obstetrics & Gynecology
  • 王劭琪 Division of Obstetrics & Gynecology
  • 林浩 Division of Obstetrics & Gynecology
  • 黃思于 Division of Obstetrics & Gynecology
  • 吳貞璇 Division of Obstetrics & Gynecology
  • 歐育哲 Division of Obstetrics & Gynecology

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Peng-Hui Wang Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator - -

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Study Contacts

- -

Condition/Disease

-

Objectives

-

Test Drug

-

Active Ingredient

-

Dosage Form

-

Dosage

-

Endpoints

-

Inclution Criteria

-

Exclusion Criteria

-

The Estimated Number of Participants

  • Taiwan

    34 participants

  • Global

    582 participants